Junevity
San Francisco
About Junevity
Junevity focuses on reversing diseases of aging through novel transcription factor medicines. The company leverages six years of breakthrough research from UCSF to develop next-generation approaches to rejuvenation. By targeting transcription factors, Junevity aims to provide innovative treatments that can potentially rewind the biological clock and improve healthspan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $20.0M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: junevity.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/junevity-42552 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.